Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Agamree 40 mg/ml oral suspension {equilateral_black_triangle}

Active Ingredient:
vamorolone
Company:  
Santhera (UK) Limited See contact details
ATC code: 
H02AB18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Patient Alert Card

Patient Alert Card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Santhera (UK) Limited
Company image
Address
1 Chamberlain Square Cs, Birmingham, B3 3AX, UK
Telephone
+44 (0)1753 972 351
E-mail
[email protected]
WWW
www.santhera.com
Medical Information e-mail
[email protected]